• Aclarion granted newly hired Commercial Director, Western U.S. Daniel Keefe an inducement stock option to buy 17,000 common shares on May 5, 2026.
• Exercise price set at USD 3.2 per share, matching closing price on grant date.
• Vesting set at 25% on one-year anniversary of vesting commencement date, remainder in equal monthly installments over next three years; option term set at 10 years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aclarion Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605060600PRIMZONEFULLFEED9713995) on May 06, 2026, and is solely responsible for the information contained therein.